Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings Co's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was 円24.35.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 円226.30.
During the past 12 months, Noevir Holdings Co's average earnings per share (NRI) Growth Rate was -3.10% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 3.40% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 7.20% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 4.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Noevir Holdings Co's EPS without NRI or its related term are showing as below:
TSE:4928'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -6.9 Med: 9 Max: 48
Current: 3.4
During the past 13 years, Noevir Holdings Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 48.00% per year. The lowest was -6.90% per year. And the median was 9.00% per year.
TSE:4928's 3-Year EPS without NRI Growth Rate is ranked worse than 56.21% of 1530
companies
in the Consumer Packaged Goods industry
Industry Median: 7.45
vs TSE:4928: 3.40
Noevir Holdings Co's EPS (Basic) for the
three
months ended in Dec. 2025 was 円38.70.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円237.35.
Noevir Holdings Co (TSE:4928) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Noevir Holdings Co EPS without NRI Related Terms
Noevir Holdings Co EPS without NRI Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4928 vs PG, CL, KVUE: EPS without NRI Comparison
For the Household & Personal Products subindustry, Noevir Holdings Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co PE Ratio without NRI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円226.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co (TSE:4928) has a EPS without NRI of 円226.30 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Noevir Holdings Co and its competitors. According to the industry distribution chart, Noevir Holdings Co ranks #860 out of 1530 companies in the Consumer Packaged Goods industry, placing it in the top 56.2%.
Is Noevir Holdings Co's EPS without NRI too high?
Noevir Holdings Co's current EPS without NRI is 円226.30. Based on the distribution chart, Noevir Holdings Co ranks #860 out of 1530 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Noevir Holdings Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's EPS without NRI compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #860 out of 1530 companies for EPS without NRI. This places Noevir Holdings Co in the lower half of its industry. The industry median EPS without NRI is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Consumer Packaged Goods company?
The median EPS without NRI among Consumer Packaged Goods companies is 7.45, based on 1,530 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Noevir Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median EPS without NRI is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current EPS without NRI is 円226.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,265.32, compared to a current price of 円4,585.00 — trading 12.9% below its estimated fair value. The current EPS without NRI is 円226.30. Noevir Holdings Co's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current EPS without NRI is 円226.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,585.00 is trading 12.9% below its estimated GF Value™ of 円5,265.32.
GuruFocus considers Noevir Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:4928:
EPS without NRI: 円226.30
GF Value™: 円5,265.32 vs. price of 円4,585.00 (12.9% below fair value)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
79GF Score
Get the complete analysis for TSE:4928
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
